drugset / Trial / NCT00167921

Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis

NCT00167921

Phase 1 Completed 24 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to characterize the systemic exposure and bioavailability at steady state of Premarin® Vaginal Cream compared with Premarin® oral tablets in postmenopausal women with atrophic vaginitis.

Timeline

Start
2005-10
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject conjugated estrogens Other / unclassified Other